Ultragenyx Pharmaceutical Inc. (RARE) › Cost of RevenueUltragenyx Pharmaceutical Inc. (RARE) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $1.0K2018: $1.15M$1.15M2017Cost of Revenue (USD)2018Fiscal YearCost of RevenueChange YoY2018$1.15M+114500.0%2017$1.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share